Par Formulations Private Limited — FDA Facility Profile
Par Formulations Private Limited is an FDA-registered facility (FEI 3007027193) located in Chennai, IN. Registered operations: ANALYSIS; MANUFACTURE; PACK. RegDataLab tracks 7 FDA inspections at this facility.
Reviewing Par Formulations Private Limited as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Par Formulations Private Limited yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
What FDA found at this site
- Latest inspection
- Jun 10, 2026: Voluntary Action Indicated (VAI)
- Inspections on record
- 7 (2 VAI, 5 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 1, latest Nov 10, 2022
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Jun 10, 2026 | Voluntary Action Indicated (VAI) | No citations listed |
| Mar 24, 2023 | No Action Indicated (NAI) | No citations listed |
| Jun 21, 2019 | No Action Indicated (NAI) | No citations listed |
| Dec 7, 2016 | Voluntary Action Indicated (VAI) | No citations listed |
| Apr 17, 2015 | No Action Indicated (NAI) | No citations listed |
| Oct 17, 2013 | No Action Indicated (NAI) | No citations listed |
| Sep 21, 2011 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Nov 10, 2022 | Class II | D-0061-2023 | Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only
Dist. by… Failed Impurities/Degradation Specifications |
Facility details
- Company
- Par Formulations Private Limited
- Location
- Chennai (IN)
- Registration Expires
- Dec 31, 2026
- Operations
- ANALYSIS; MANUFACTURE; PACK
- Source
- decrs